( Survey Shows 89% of Patients Prefer Ora...)Orapred ODT Tastes Good,Health

ALPHARETTA, Ga., March 29, 2007 /PRNewswire/ -- Alliant Pharmaceuticals announced today survey results showing that children prefer Orapred ODT(TM) (Prednisolone sodium phosphate orally disintegrating tablets) over liquid steroids.(1)

The results of the patient feedback survey involving more than 900 children (n=973), showed that 89% (n=870) of the children preferred Orapred ODT over liquid versions. The results also showed that 83% (n=809) of the respondents liked the taste of Orapred ODT, and 97% (n=942) said Orapred ODT was easy to take. In addition, 96% (n=937) of the patients reported that they were able to take all of their medication as prescribed.

Orapred ODT is the first orally disintegrating tablet form of prednisolone available in the United States. Orapred ODT is prescribed primarily for acute exacerbations of asthma in children. It is also used to control severe, persistent asthma and to reduce inflammation seen in numerous medical conditions including arthritis and cancer. The indication and important safety information for Orapred ODT is listed below.

"Orapred ODT's exclusive taste-masking technology helps disguise prednisolone's typically bitter taste," said Mark Pugh, President of Alliant Pharmaceuticals. "We are pleased to see that, based on these results; patients appreciate both the taste and convenience that Orapred ODT has to offer."

Orapred ODT utilizes a proprietary orally disintegrating tablet technology to provide a taste-masked, non refrigerated and convenient formulation of prednisolone.

Alliant Pharmaceuticals sponsored the survey that was initiated in September, 2006 and ran until December 2006. Patients were included in the multi-center survey if they required steroid burst therapy for asthma exacerbation and were required to have taken a liquid steroid in the past. Physicians were instr
'"/>